{"id":"W2398489629","doi":"10.1016/j.jacl.2016.03.091","title":"Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Concomitant; Familial hypercholesterolemia; Monoclonal antibody; Monoclonal; Internal medicine; Antibody; Immunology; Pharmacology; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006780286,0.0002915729,0.001082655,0.0002323607,0.0002867696,0.0004860823,0.0002093465,0.0006356206,0.0005546916],"category_scores_gemma":[0.001329334,0.0001611968,0.0007985237,0.0002131079,0.000274214,0.0004071995,0.0001432834,0.001069548,0.0001499833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004228173,"about_ca_system_score_gemma":0.0003973775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004153118,"about_ca_topic_score_gemma":0.0006816348,"domain_scores_codex":[0.9996699,0.0001162115,0.00003886291,0.00005716048,0.00005983715,0.00005808155],"domain_scores_gemma":[0.9993802,0.0002116079,0.0001533967,0.00004383194,0.00004746455,0.0001634821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4328386,0.004829844,0.3171096,0.0005491638,0.003396307,0.002747068,0.000330026,0.002136746,0.045869,0.0004437232,0.001625968,0.1881239],"study_design_scores_gemma":[0.05397268,0.1099728,0.797327,0.000216261,0.005422135,0.005920536,0.00030228,0.007567568,0.01145087,0.0008394972,0.006884845,0.0001236113],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996039,0.002887953,0.0001529076,0.0001259152,0.00003083652,0.00001723985,0.0000914893,0.00000960638,0.0006450378],"genre_scores_gemma":[0.9989216,0.0004971308,0.00008086165,0.0001333014,0.00004928245,0.00001712387,0.0001515863,0.000002412432,0.0001467037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001082655,"threshold_uncertainty_score":0.003585815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02605880585477787,"score_gpt":0.3492966586776308,"score_spread":0.3232378528228529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}